Novel Biomarkers in Chronic Airway Diseases

This study is currently recruiting participants.

Verified by Chonbuk National University, February 2009

First Received: February 23, 2009 No Changes Posted

Sponsored by:	Chonbuk National University
Information provided by:	Chonbuk National University
ClinicalTrials.gov Identifier:	NCT00849836

Purpose

The purpose of this study is:

To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Condition
Asthma COPD

Study Type:	Observational
Study Design:	Case Control, Prospective
Official Title:	The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Further study details as provided by Chonbuk National University:

Estimated Enrollment:	30
Study Start Date:	February 2009
Estimated Study Completion Date:	January 2010

Eligibility

Study Population

Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

Criteria

Inclusion Criteria:

> 18 years olds
Both sexes
Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00849836

Contacts

Contact: So Ri Kim, MD, PhD	82-63-250-2475	sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD	82-63-250-1664	leeyc@chonbuk.ac.kr

Locations

Korea, Republic of
Chonbuk National University Medical School	Recruiting
Jeonju, Korea, Republic of, 561-180
Contact: So Ri Kim, MD, PhD sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD leeyc@chonbuk.ac.kr
Principal Investigator: Yong Chul Lee, MD, PhD
Sub-Investigator: So Ri Kim, MD, PhD

Sponsors and Collaborators

Chonbuk National University

More Information

No publications provided

Responsible Party:	Chonbuk National University Medical School ( Yong Chul Lee )
Study ID Numbers:	RCPD
Study First Received:	February 23, 2009
Last Updated:	February 23, 2009
ClinicalTrials.gov Identifier:	NCT00849836 History of Changes
Health Authority:	Korea: Food and Drug Administration

Study placed in the following topic categories:

Asthma
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on August 30, 2009